Partner portal 
19001717 
Detect 40 HPV types in a single test
Most women with HPV do not experience any noticeable signs or symptoms. However, certain HPV types may cause genital warts, while high-risk types associated with cervical cancer may not produce any obvious symptoms.
Regular HPV testing is recommended as an effective way to detect high-risk HPV infections early, even when no symptoms are present.
Of the more than 200 identified HPV types, approximately 14 are classified as high-risk types associated with cervical cancer.
HPV 16 and HPV 18 are the two most common high-risk types and are responsible for approximately 70% of cervical cancer cases worldwide.
Other high-risk types, including HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, have also been associated with the development of precancerous cervical lesions and cervical cancer when the infection persists.
HPV testing has high sensitivity for detecting high-risk HPV types associated with cervical cancer, making it one of the most effective screening methods currently available.
However, a positive result does not mean that cancer is present. It only indicates the presence of HPV and should be followed by further evaluation, such as a Pap smear or colposcopy, to establish an accurate diagnosis.
Even if you have received the HPV vaccine, regular cervical cancer screening is still recommended because the vaccine does not protect against all high-risk HPV types that can cause cancer.
No. Currently, there is no routinely recommended HPV screening test for men. Therefore, DIAG’s HPV 16 / 40 testing packages are intended for women only.
Men with lesions suspected to be caused by HPV should consult a DIAG urologist/andrologist for further evaluation.
